Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Upstream Bio (UPB) Non Operating Income (2023 - 2025)

Upstream Bio has reported Non Operating Income over the past 3 years, most recently at $54000.0 for Q4 2025.

  • Quarterly results put Non Operating Income at $54000.0 for Q4 2025, down 99.64% from a year ago — trailing twelve months through Dec 2025 was $8.8 million (down 53.71% YoY), and the annual figure for FY2025 was -$15000.0, down 100.1%.
  • Non Operating Income for Q4 2025 was $54000.0 at Upstream Bio, down from $4.1 million in the prior quarter.
  • Over the last five years, Non Operating Income for UPB hit a ceiling of $15.0 million in Q4 2024 and a floor of -$50000.0 in Q2 2025.
  • Median Non Operating Income over the past 3 years was $25500.0 (2024), compared with a mean of $2.8 million.
  • Biggest five-year swings in Non Operating Income: surged 214128.57% in 2024 and later tumbled 233.33% in 2025.
  • Upstream Bio's Non Operating Income stood at -$7000.0 in 2023, then surged by 214128.57% to $15.0 million in 2024, then tumbled by 99.64% to $54000.0 in 2025.
  • The last three reported values for Non Operating Income were $54000.0 (Q4 2025), $4.1 million (Q3 2025), and -$50000.0 (Q2 2025) per Business Quant data.